1442472-39-0} ripretinib

Cov Khoom Siv

Cov tsos dawb rau lub teeb daj
Boint Taw tes: 568.6 ± 5 0. 0 degree
Ntsej Muag 1.544 ± 0. 06 g / cm3
Cia temp. Khw ntawm -20 degree
Solubility DMOPS: 25. {0 (mL / ml); {}} (max)
PKA12.15 {0. 70
 

Daim Ntawv Thov:

Ripretinib yog Tyrosine Kinase inhibitor uas ua rau cov khoom siv thiab PDGFra Kinases, thiab yog qhov tsim nyog rau kev kho cov neeg laus cov neeg laus uas muaj peb lossis ntau dua kinease inibitors, suav nrog imatinib.
 

 

Cov lus txhais lus:

Ripretinib

1442472-39-0

DCC -2618

N - {{{{4- bromo -5- [}} (Methylamino) {5} } Oxo -1}, {{}}}}}}} -3- YL] {-2- fluorophenyyl} -n'-phenyesa

Urea, n - {{{4- bromo {}}}}}}}} {} {} {9}} naphthyridin -3- yl] -2- fluorophenyl] -n'-phenyl -39-0

qinlock

Ripretinib pub dawb luj

Qua kab

1- (4- bromo {}}}}}}}} {}} di Hydro -1, {{{}}} {} {{{{penylurea

Ripretinib

1442472-39-0 (pub dawb)

Urea, N - ({4- bromo {2}}}}}}}} (metylamino) { 7}} Oxo -1}}} {}}}} {} {}}}}}} {-phenyl-

N - ({4- bromo -5-}}}}}}} {} {}} dih ydro -1, 6-}}} {}}}}} Cov fluylophenyl) -n'-phenylenea

{{0 {0}} [4- bromo {}}}}}} oxo { }}, {{6- naphthyridin {}} {9 {}} Phenylurea

ripretinibum

{{0 {0}} {{{{4-}}}} {} {oxo {{6 }}, {{6-} naphthyridin {} {9 {-1- Phenylurea

C24h2h2brfn5o2

Ripretinib (DCC -2618)

Cov Khoom Siv / PDGF Inflicitor DCC -2618

DCC 2618; DCC2618; Cov Khoom Siv / PDGFR inhibitor; ripretinib

1- n '- (2, {}}}}} Methylpyazol {{} yl) pyridin -4- yl) oxyphenyl) -1-}} {}} dicarboxamide

{{0 {}} {{{{4-}}}}}}}} {} {} i}} i}} i Hydro -1, {9}}} {} {{{{{penylurea

Ripretinib; Urea, N - {{4- bromo -5-}}}}} (Methylamino) { }} Oxo -1, {9}}}} {} {} {}} {} {} {{'-phenylas)-tenyyl-; N - {4- bromo {} 17}}}}}}} (Methylamino) {2 2}} Oxo {23}}}}} {24}}} {}} Cov fluorophenyl] -n'-phenylenea; 1- [4- bromo {}}}} {33}} (Methyla

 

Cim npe nrov: 1442472-39-0} ripretinib, Tuam Tshoj {1442472-39-0} ripretinib manufacturers, lwm tus neeg